Ad
related to: can azathioprine cause weight gain and bloating in stomach women over 70
Search results
Results From The WOW.Com Content Network
How to Reset Female Hormones For Weight Loss. This article was reviewed by Craig Primack, MD, FACP, FAAP, MFOMA. Hormones can be helpful heroes, supporting the immune system and a healthy sleep ...
Azathioprine, sold under the brand name Imuran, among others, is an immunosuppressive medication. [5] It is used for the treatment of rheumatoid arthritis , granulomatosis with polyangiitis , Crohn's disease , ulcerative colitis , and systemic lupus erythematosus , and in kidney transplants to prevent rejection .
In the most extreme cases, upward pressure on the diaphragm and lungs can also cause shortness of breath. Through a variety of causes (see below), bloating is most commonly due to buildup of gas in the stomach, small intestine, or colon. The pressure sensation is often relieved, or at least lessened, by belching or flatulence. Medications that ...
"It can float to the top in the stomach, giving a sensation of bloating," Litt says. "Also, some of these drinks have artificial sweeteners, which cause more bloating." High fiber foods
Cons: Doing heavy exercise can cause blood to flow into whatever part of the body is being worked, which draws blood away from the stomach, where it may be needed for digestion, says Dr. Nazareth ...
The most common symptom associated with bloating is a sensation that the abdomen is full or distended. Rarely, bloating may be painful or cause shortness of breath. [citation needed] Pains that are due to bloating will feel sharp and cause the stomach to cramp. These pains may occur anywhere in the body and can change locations quickly. [8]
With bloating, says Dr. Lee, “the hormonal fluctuations during your menstrual cycle can cause constipation or insufficient or adequate defecation,” says Dr. Lee. “Stool that stays in the ...
Thiazolidinediones may cause slight weight gain but decrease "pathologic" abdominal fat (visceral fat), and therefore may be prescribed for diabetics with central obesity. [115] Thiazolidinedione has been associated with heart failure and increased cardiovascular risk; so it has been withdrawn from the market in Europe by EMA in 2010. [116]